DE60006116D1 - A2a rezeptor agonisten - Google Patents

A2a rezeptor agonisten

Info

Publication number
DE60006116D1
DE60006116D1 DE60006116T DE60006116T DE60006116D1 DE 60006116 D1 DE60006116 D1 DE 60006116D1 DE 60006116 T DE60006116 T DE 60006116T DE 60006116 T DE60006116 T DE 60006116T DE 60006116 D1 DE60006116 D1 DE 60006116D1
Authority
DE
Germany
Prior art keywords
receptor agonists
disclosed
purposes
alkylthienyl
adenosines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60006116T
Other languages
English (en)
Other versions
DE60006116T2 (de
Inventor
A Zablocki
O Elzein
P Palle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gilead Palo Alto Inc
Original Assignee
CV Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CV Therapeutics Inc filed Critical CV Therapeutics Inc
Publication of DE60006116D1 publication Critical patent/DE60006116D1/de
Application granted granted Critical
Publication of DE60006116T2 publication Critical patent/DE60006116T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60006116T 1999-06-22 2000-06-20 A2a rezeptor agonisten Expired - Lifetime DE60006116T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14047899P 1999-06-22 1999-06-22
US140478P 1999-06-22
PCT/US2000/016856 WO2000078776A2 (en) 1999-06-22 2000-06-20 Thiophene a2a receptor agonists

Publications (2)

Publication Number Publication Date
DE60006116D1 true DE60006116D1 (de) 2003-11-27
DE60006116T2 DE60006116T2 (de) 2004-07-08

Family

ID=22491411

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60006116T Expired - Lifetime DE60006116T2 (de) 1999-06-22 2000-06-20 A2a rezeptor agonisten

Country Status (19)

Country Link
US (1) US6440948B1 (de)
EP (1) EP1194441B1 (de)
JP (1) JP2003502434A (de)
KR (1) KR100463694B1 (de)
CN (1) CN1166677C (de)
AT (1) ATE252595T1 (de)
AU (1) AU768530B2 (de)
BR (1) BR0011853A (de)
CA (1) CA2373410C (de)
DE (1) DE60006116T2 (de)
ES (1) ES2206259T3 (de)
HK (1) HK1048821B (de)
IL (2) IL147194A0 (de)
MX (1) MXPA01013323A (de)
NO (1) NO20016242L (de)
NZ (1) NZ516336A (de)
TR (1) TR200200617T2 (de)
WO (1) WO2000078776A2 (de)
ZA (1) ZA200200299B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2347512C (en) * 1998-10-16 2005-12-06 Pfizer Inc. Adenine derivatives
CN1279984C (zh) 2002-02-15 2006-10-18 Cv医药有限公司 用于医用装置的聚合物涂层
TWI346109B (en) * 2004-04-30 2011-08-01 Otsuka Pharma Co Ltd 4-amino-5-cyanopyrimidine derivatives
PT1758596E (pt) * 2004-05-26 2010-06-23 Inotek Pharmaceuticals Corp Derivados de purina como agonistas do receptor de adenosina a1 e processos para a sua utilização
RU2007114887A (ru) * 2004-09-20 2008-10-27 Инотек Фармасьютикалз Корпорейшн (Us) Производные пурина и способы их применения
CN101321460A (zh) * 2005-11-30 2008-12-10 伊诺泰克制药公司 嘌呤衍生物及其用法
EP2523669B1 (de) 2010-01-11 2016-12-07 Inotek Pharmaceuticals Corporation Kombination, kit und verfahren zur reduzierung des augeninnendrucks
AU2011230580A1 (en) 2010-03-26 2012-10-11 Inotek Pharmaceuticals Corporation Method of reducing intraocular pressure in humans using N6 -cyclopentyladenosine (CPA), CPA derivatives or prodrugs thereof
PL2807178T3 (pl) 2012-01-26 2017-12-29 Inotek Pharmaceuticals Corporation Bezwodne polimorfy azotanu (2R,3S,4R,5R)-5-(6-(cyklopentyloamino)-9H-puryn-9-ylo)-3,4-dihydroksytetrahydrofuran-2-ylo)metylu i sposoby ich wytwarzania
MX2015013234A (es) 2013-03-15 2016-04-15 Inotek Pharmaceuticals Corp Formulaciones oftalmicas.
EP3568153A4 (de) 2017-01-13 2020-09-16 Tobishi Pharmaceutical Co., Ltd. Regler der neutrophilen aktivierung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK135130B (da) * 1970-12-28 1977-03-07 Takeda Chemical Industries Ltd Analogifremgangsmåde til fremstilling af 2-substituerede adenosinderivater eller syreadditionssalte deraf.
JPS4911896A (de) * 1972-05-15 1974-02-01
JPS5518625B2 (de) * 1973-07-26 1980-05-20
US5070877A (en) * 1988-08-11 1991-12-10 Medco Research, Inc. Novel method of myocardial imaging
DK0508687T3 (da) * 1991-04-06 1996-02-05 Astra Pharma Prod ATP-analoger

Also Published As

Publication number Publication date
BR0011853A (pt) 2002-04-30
EP1194441A2 (de) 2002-04-10
CN1166677C (zh) 2004-09-15
IL147194A0 (en) 2002-08-14
US6440948B1 (en) 2002-08-27
KR20020028912A (ko) 2002-04-17
NO20016242L (no) 2002-02-21
ES2206259T3 (es) 2004-05-16
NZ516336A (en) 2004-01-30
ZA200200299B (en) 2003-08-27
CA2373410A1 (en) 2000-12-28
AU5625100A (en) 2001-01-09
MXPA01013323A (es) 2003-10-15
TR200200617T2 (tr) 2002-06-21
WO2000078776A2 (en) 2000-12-28
WO2000078776A3 (en) 2001-06-28
HK1048821B (zh) 2005-02-25
EP1194441B1 (de) 2003-10-22
AU768530B2 (en) 2003-12-18
JP2003502434A (ja) 2003-01-21
HK1048821A1 (en) 2003-04-17
CA2373410C (en) 2006-08-29
KR100463694B1 (ko) 2004-12-29
CN1364170A (zh) 2002-08-14
NO20016242D0 (no) 2001-12-19
ATE252595T1 (de) 2003-11-15
DE60006116T2 (de) 2004-07-08
IL147194A (en) 2007-08-19

Similar Documents

Publication Publication Date Title
BRPI0011856B8 (pt) agonistas de receptor a2a de n-pirazol
BR0011854A (pt) Agonistas de receptores de a2a de c-pirazola
NZ522326A (en) Adenosine A2A receptor antagonists
ATE252595T1 (de) A2a rezeptor agonisten
MA26699A1 (fr) Derives d'adenine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MY148937A (en) Medicaments with hm74a receptor activity
TR200201001T2 (tr) Pürin türevleri
DE69223914T2 (de) 4-substituierte-2-Deoxy-2,3-Didehydro Alpha-D-Neuraminsäure antivirale Derivate
DK0975595T3 (da) Kokainanaloger
NO20021448L (no) Nye tiazolo-(4,5-D)pyrimidinforbindelser
BR0011850A (pt) Agonistas de receptor a2a de propargil fenil éter
BR0111438A (pt) Análogos de ácido barbitúrico como agentes terapeuticos
TR200103680T2 (tr) IL-8 reseptör antagonistleri.
EA200200562A1 (ru) Антагонисты аденозиновых рецепторов и способы их получения и использования
ATE389655T1 (de) Pyrimidinderivate
FR2618435B1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique
FR2597097B1 (fr) Derives de benzothiazepine-1, 5, leur preparation et leur application en therapeutique
EE03876B1 (et) Aminohappe estrit sisaldavad asool-antimükootikumid, nende valmistamine ja kasutamine ning neid sisaldavad farmatseutilised kompositsioonid
CN100480255C (zh) A1腺苷受体的部分和完全激动剂
ES2222975T3 (es) Uso de antagonistas de pirimidina endotelina en animales de compañia.
CA2304821A1 (en) Osteoblast-specific mitogens and drugs containing such compounds
ATE260118T1 (de) Zusammensetzungen von adenosin a1 agonisten mit 5ht1 agonisten
SE9903609D0 (sv) Novel compounds I

Legal Events

Date Code Title Description
8364 No opposition during term of opposition